TRPM8 inhibitor, namely AMTB at very low concentrations could provide an opportunity for their therapeutic use in enhancing osteogenesis and could be relevant for treatment of different bone-related disorders such as osteoporosis where more bio-mineralization is required. This evidence concerns the gene TRPM8 and osteoporosis.